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INTRODUCTION 
Vitamins hA.V9 entered the lives of the people 
today with almost bombastic force. We are continually 
made conscious of their nresence by advertisements, in 
printed form or by radio. These advertising media 
fling their challenge -- "Have you had your vitamins 
today?" That a new vitamin should make 1 ts aJrnearance 
at this stage of vitamin popularity is appropos of the 
present times and their advancement. 
The vitamin is K. 
A few years ago, a young Scandinavian, Dam, and 
his associates ( 3,, 35), described a severe hemorrhagic 
disorder associated with plasma prothrombin deficiency. 
The causative factor was a deficiency of certain fat 
soluable substances :from an otherwise adequate diet. 
Their experiments were nerformed upon chicks. (30, 2..f) 
The factor deficient from the diet of the 
chicks and responsible for the hemorrhagic tendencies 
of the chicks was called KOAGULATIONS V!TAMIN, in the 
German and Scandinavian language. The abbreviated form 
and the name by which it is most connnonly known today, 
i s Vitamin K. 
Vitamin K is proving to be of value in the 
clinical aspect of medicine, especially in surgery and 
obstetrics. 
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The aim and nurpo se of this paper is to point 
out the chemistry and physiology of the vitamin, as 
well as its occurance in nature and the estimation of 
prothrombin. This being shown adeauately, the next 
purnose of this article is to show the part Vitamin K 
plays in jaundice, by its action upon prothrombin 
levels and the clotting time of the blood ulasma. 
This is with reference to jaundice occurring due to 
biliary fistula and to obstruction of the biliary ducts. 
Jaundice has been known since antiquity. T.b.e 
deleterious effect it has upon the clotting time of the 
blood has been kn.own since the advent of surgery. 
Vitamin K, I firmly believe, will be a powerful weapon 
for the surgeon in the treatment of hemorrhage occurr-
ing because of the obstructive jaundice and biliary 
fistula. By its us~ge, he will be able to onerate when 
the operation is vitally needed. 




A search for an anti-hemorrhagic factor, which 
was precipi t:lted by Dam and As sac's discovery of a b•/JJ,JS) 
hemorrhagic disorder attributable to a dietary defici-
ency, has been carried on intensively And unceasingly 
by investigAtors. The trial and error method was ob-
viously the only method to use in the search of the 
source and distribution of the a.nti-hemorrhagic factor. 
Dam and Assac ran a series of tests and found 
the factor to be contained in the following in varying 













Soy Bean ( 12 







These were examined and found to nossess protective 
qualities for the hemorrhagic entity. Alfalfa proved (7~ 
to be quite efficacious in raisin~ the prothrombin level 
in chicks, while sunflower seeds. and roots nroved to be 
a poor source for the factor. 
'Ille vitamin or anti-hemorrhagic factor was found 
to be in the photosynthetic portion of the plant, by ( ~ 
Almquist. This is proven by the fact that the tops of 
carrots contained the vitamin, while the rest of the 
carrot did not. The leafy portion of plants proved to 
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be a good source of Vitamin K. Almquist, Dam and Stok-
stad (3~ .3,7~ began using an extract of alfalfa with good 
results. A short time later, fish were found to be 
rich in the vitamin, if allowed to putrify before ex-
tracting the vitamin. 
Osterberg ( s 1 and Butt, et al, (A.'- ) found 
the extract of fish meal to be satisfactory, in their 
experiments on Vitamin K. Almquist, Dam, Stokstad and 
Glavind used extracts of alfalfa. Next, spinach made 
its apnearance, and was used by Dam, et al, in their 
experiments. Dam designated 2 mg. of sninach as a unit 
of potency of the vitamin. 
Vitamin K from putrified fish and the photo-
synthetic portion of plants, remained the principal 
source, until Almquist and Stokstad found the vitamin 
in feces of chicks. ( ~ Greaves ( 'io ) arrived at 
a similar conclusion from his exneriments with rats. 
These findings focused attention upon the possibility 
of a synthesis of Vitamin Kin the intestinal tract. 
Greaves ( 3' ) ( '+o ) , by using the extract of 
droppings of chicks which had been allowed to drop into 
1% phenol, pointed out that synthesis of the Vitamin K 
takes place in vivo. 
&'nell ( '7 ), working on the source of Vitamin 
K and its possible synthesis in the intestinal tract, 
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found thnt c ert71.in bacteria contain the vi tAX1in. 
Escherichi.; coli, StA'l')hylococcus aureus, Bacillus 
subtilis and microorganisms were found to h11ve the 
vitamin, even when gro,•m 1rnon vi tRmin free media, 
indicnting it to be a product of bacterial metabolism. 
Almciuist and Yiose ( g' ) then identified the 
form of Vitamin K (phthiocol) as the Pigment of Myco-
bacterium tuberculosis (human). This pigment had been 
previously synthesized by .Anderson and co-workers. 
( 13 ) The possibility that Vitamin K, or a substance 
possessing the anti-hemorrhagic characteristics of 
Vitamin K, could be synthesized onened a new source 
for obtaining the vitamin. ( 37 ) 
Fei ser, et Al, ( J ( ) and other investigators, 
working on the structure of the vitamin, found the ac-
tive portion to be due to its naphthoauinone nucleous. 
Next, .Ansbacher ( 15 observed that Vitamin Kand other 
phytyl (natural) derivatives of methyl naphthoquinone are 
not as active and not as readily utilized by the animal 
body as 2-methyl-1-4, nanhthoouinone, which is not from 
nature, but synthesized in the 111boratory. This man-
made product proves to be more potent, more rapidly 
absorbed and more easily utilized by the body, than the 
Vitamin K obtained from nature. 
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In summarizing, we see the principal source 
of the anti-hemorrhagic factor is the photosynthetic 
portion of plants, putrified fish, hog liver oil, 
bacterial and synthetic source. 
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CHJ!MISTRY 
In 1935, Hendrik Dam ( .3 o ) , while working 
on the nature and distribution of the anti-hemorrhagic 
factor, discovered thr-i.t the factor is a fat soluable 
vitamin, occurring in hog liver, hemp seed and vege-
tables. The anti-hemorrhagic factor was localized in 
the fat soluable, unsaponifiable, non-sterol fraction. 
It proved to be stable to moderate heating. 7 ) ( 71 
In the early stages of the work on the anti-
hemorrhagic vitamin, the extracted material was 
saponified in alcoholic potassium hydroxide to remove 
the fat and chlorophyll. Alfalfa was the source used. 
The extraction was performed by using hexane. This 
hydrocarbon solvent extracts less extraneous material 
than other tynes of solvents. It soon became apparent, 
however, that the non-saponified :rraction had up to 
50% less notency than the crude extract. FUrther 
treatment of a non-saponifiable preparation with al-
kali resulted in the loss of more than ?5% of its 
activity. This showed th::it the vitamin was alkali la-
bile. 
It rEmained for Almquist ( ~ ) to add the next 
step to the knowledge of the new vitamin. He ( 7 ) had 
previously obtained concentrates of high potency by add-
ing activated magnesium oxide (in place of the alkalis) 
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to the hexane extract, causing no loss of potency of 
the extrAct. Next, activated carbon was added to 
remove in part the orange and red pigment remaining, 
the carotene and xanthophyll. Following this, the 
step of concentrating the hexane solution and chill-
ing out the fats and sterols. The hexane solution 
was evaporated to dryness under a vacuum. The solid 
residue was taken up with methyl alcohol at fifty 
degrees. This was chilled for twenty-four hours at 
a negative 1.1 degrees. The solution was then c entri-
fuged, the solid reddish material containing sterols 
being discarded. The solution was again chilled, and 
the nrocess reneated. Finally, upon the addition of 
10 c.c. of water to the mixture, there ensued a separa-
tion of about 2 c.c. of a reddish oil. This was dried 
under a vacuum and dissolved in hexane, then allowed 
to evanorate under a vacuum at room temnerature. 
These reddish oils contained the Vitamin K • 
.Almquist ( &1 ) , by using these concentrates 
in a specially constructed retort which had a heating 
element constructed about the closed end of the re-
tort, was able for the first time to obtain the anti-
hemorrhagic factor in a crystalline form. It ( (, ) 
was determined, at this tjme, bv Almquist, that the 
final attainment of a colorless concentrate shows the 
- 9 -
vitamin to be colorless. It was during this experi-
ment that he confirmed his previous finding ( / o ) , 
namely, that the ~nti-hemorrhagic factor, Vitamin K, 
contAined the Benzene Ring or nucleus. 
Binkley, et al, ( 11 ) by the use of decolso, 
permutit and dorco as absorbents, hr:ive isolated Vita-
min K in a nractically pure state. Then, crystalliza-
tion, distillr:ition and recrystallization gave the nure 
vitamin. Next, they converted the vitamin into the 
diacetate of dihydro Vitamin K with a notency of 500 
units per mg. Then, by means of the Grignard reaction, 
the diacetate has been converted back to Vitamin K, 
with 100% enhancement of potency, 1000 units per mg. 
This is an improvement over Almquist's method, in that 
he lost 50% of the vitamin and the concentration was 
unpredictable. 
Vitamin K2 was converted to the diacetate of 
dihydro Vitamin K2 by the same method used for Vitamin 
Kl. Binkley, et al, ( 19 ) offered this as proof that 
Vitamins Kl and K2 have been isolated. The names, 
Vitamin lG. and Vitamin K2, were given by Binkley, et 
al ( .2t:f.: ) • In their article on "'llie Isolation of 
Vitamin K0 11 ) , they exnlained their terminology 
as :follows: "Since two dif'ferent -pure substances 
possessing Vitamin K activity were isolated, the 
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compound from alfalfa, which has the smaller molecu-
lar weight, was called Vitamin Kf. and the compound 
from nutrified fish meal having the larger molecular 
weight, Vitamin K2." 
During the Past year, observations made by 
Almquist and IG.o se ( 5 ) ( t ) ( 11 ) ( ..s ) ( - ) , 
have revealed that the nanhthoquinone structure con-
stitutes the essential structure of Vitamin K. A 
variety of naphthoquinones may cure the Vitamin K 
deficient chicks and other species, some in as low 
amounts as one mg. 
Accord1.ng to Binkley, et al, ( .2.o ) Vitamin Kl 
is, as follows: 
1. Obtained from alfalfa; 
2. Vitamin K -- light yellow oil at room 
temperature; 
3. Changes u~on cooling into a crystalline 
condition; 
4. Potency of about 1000 units per mg. ( ~/ 
5. Molecular Weight estim,,.tes vary from 
443 to 568; 
6. Absorption maxima 243,248,261,2?0 and 
323 Mu.; 
? • Structural formula was found to be 
2-Methyl, 3-Phytyl ... 1, 4-N aph thoquinon e. 
( Ir) 





1. Obtained from fish meal; 
2. Molecular weight estimates vary from 
628 to 654; ( I ~ ) 
3. Potency approximately 600 units per mg. 
( 'l.I ) 
4. Absorption maxima 244, 249, 264, 270, 
332; ( 37 ) 
The chemical structure and formula of Vitamin 
K2 was recently revealed by Binkley, et al, ( ~')...) at 
the 34th Annual Meeting of the .American Society of 
Biological Chemists, held March 13-16, 1940. 
"A model experiment in which the diacetate of 
dihydro Vitamin Kl gave an excellent yield of 1, 4-
diacetoxy-2-methylnaptholene-3-acetaldhyde, which was 
further characterized as the semi-carbozone. Ozoniza-
tion of the diacetate of dihydro vitamin K2 under the 
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same condition gave 1, 4-diacetoxy-2-methylnaptholene 
-3 ac etaldehyde. Annlysis and mixed melting point 
showed this aldehyde as well as its semicarbozone to 
be identical with the sr-ime compound obtained from 
Vitamin K. The isolntion of this aldehyde shows con-
clusi vely th~t Yi tAmin K2 is a 2-met'tyl-l, -'l:-naph-
thoquinone. From the ozonization reaction, levulin-
aldehyde was isolated ns the bis-2, 4-dinitrophenyl-
hydrozone in 811G yield, based on the assumption that 
one mole of the vitRmin would yield five moles of 
1 evulin-aldehyde~' 
'
1 Acetone was also isol::ited from the ozoniza-
tion mixture in 56% yield, assuming that one mole of 
acetone originates from one mole of Vitamin K2. The 
acetone was characterized as the 2, 4-dinitrophenyl-
hydrozone and by idiometric titration." 
c41 H56 C2 is the empirical formula proposed 
as correct for Vitamin K2. 
0 ,, 
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Ansbacher ( 1~ ) stated that Vitamin IQ and 
other phytyl deriv~tives are not as active, nor as 
readily absorbed by the animal system as 2-methyl-1 
-4-naphthoquinone, which is actually the nucleus of 
Vitamin IU and Vitamin K2. 
E:nmet, et al, ( 3 lo ) have found thnt of the 
various com~ounds prepared in their laboratory 4-
amino-2-methyl-1-na.phthol and 4-amino-3-methyl-1-
naphthol are the most potent and easiest to utilize. 
These preparations are taken up by the body more 
readily than the Vitamin Kl and Vitamin K2. These 
prenRrr-itions likeVlri se will go j_nto solution, thus 
rendering them ~wail able and sui t11ble for injection. 
'Ihese laboratory prenarations owe their solubility 
in solutions and their greater ease of utiliza.tion 
in the htunan body to the difference in structure from 
that of Vitamin IQ and Vitamin K2. The difference 
lies in the fact that these nreparations have the 1 
and 4 positions, hydroxy group and the amino group. 
The fact that these laboratory prenared com-
pounds ·will go into solution, are three times as 
active as Vitamin Kl, and are easily utilized by the 
body, promises to add a nevi concept to the anti-
hemorrhagic therapy. ( 3~ ) 
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New advancement will in all probability take 
nlace through these nffiv prenarations. The amino 
group will react with HCl to form the chloride of the 




-~ Hj ·CHJ 
Q, > 
I •• t1t-l~·f1CL () 
We see, therefore, both Vitamin Kl and Vitamin 
K2 have the same nucleus, namely, a 2-methyl-1,-4-
naphthoquinone. 
The difference lies in their side chains. Vita-
min Ki. possesses the following side chain: 
.,.,- CH_, 
CH :2- CH : C - ( CH.a Lr - CH (CH ) a - CH ( CH ) CH 
CH ~ CH J. -7 CH .a. J -- CH 
~ ~ 
Vitamin K:2 possesses this side chain: 
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PHYSIOLOGY 
The chief functions of Vitamin Kin the body, 
so far as is known, appears to lie in its utilization 
by the liver for the maintenance of a normal concentra-
tion of prothrombin in the blood plasma. Until the 
enigma of prothrombin, namely, its chemistry, has been 
solved, the mechanism by which the vi tArnin affects nro-
thrombin will probably remain obscure. 
llBecause of their bearing upon the development 
of clinical states of Vitamin K deficiency, attention 
has been focused unon factors which influence the ab-
sorntion of Vitamin K. Perhaps the most imnortant of 
these are the bile SRl tsr'. ( .i.1 
Proof for this fact may be seen in the absence 
of an adequate amount of bile salts from the intestines. 
This can be observed in obstructive jaundice and bile 
fistula. A resultant fall in prothrombin of the Pl As-
ma occurs, while on the other hand, unon administration 
of bile salts, a resultant rise is seen in the plasma 
prothrombin. 
Rhodes ( 5 ~ ) states that sodium deoxycholAte 
is probably the most effective bile salt per unit 
weight. He fUrther states th~t the hemorrhagic ten-
d ency in jaundice is due to a deficiency in plasma 
prothrombin, which in turn, is due to a K avitaminosis, 
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ano tbis results from a l:qck or absence of bile S!'llts, 
in the intestinal tract. 
Greaves ( to ) came to the conclusion that 
bile in the intestine is necessary for absorntion. 'ro 
nrove his contention, he ligated the biliary ducts of 
rats, and maintained them on a stock diet. The rats 
became icteric, with a loss in prothrombin a.nd also, a 
loss in the coagulabili ty of the blood. VJhen the flow 
of bile was again established into the intestinal 
tract, the prothrombin level increased, as did the 
coagulability of the blood to normal, within a short 
neriod of time. 
Greaves kent his experimental rats on a low 
fat diet for a period of 30 to 35 days. Then a con-
dition was noted, where the animals when inflicted 
with small cuts, underwent prolonged bleeding. 'l'he 
prothrombin levels were low. Administration of 2 -
3 c. c. of beef bile brought the nrothrombin level up 
markedly. Here the loi.q stock diet contained enough 
alfalfa to supnly the normal demnnd for Vitamin K, 
yet the bile fistula rats developed loss of blood 
coagulability upon maintenance on this diet. Only 
when bile s!'ll ts were added, or massive amounts of 
Vitamin K, did the coagulr:ition time of the blood re-
turn to normal. These exneriments point towards a 
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ve-ry significant possibility, that bile salts act as 
a carrying agent for Vitamin K across the intestinal 
tract. 
Brinkhous, et al, ( >3 ) have studied the 
effect of feeding bile or bile salts supnlemented 
with a fat soluable extract of alfalfa on the pro-
thrombin level, in a number of cases of obstructive 
jaundice with hypoprothrombinemia. '.Ihey f01md that 
the feeding of bile alone gave a rise 1n prothrombin 
level, but the rise was very gradual. In contrast, 
they obtained a ranid rise in the prothrombin level 
upon administering the bile and alfalfa extracts. 
In two of their cases, the prothrombin level rose 
ranidly during periods of increasing jaundice, indi-
cating jaundice ner-se is not the essential factor. 
Hawkins A.nd Brinkhous ( 'f 3 ) fed bile to 
bile fistula dogs, and kept the plasma prothromb:in 
levels within the limits of normal. The dogs were 
kept on a diet which contained Vitamin Kin small 
quani ti es. 
Sn ell ( t, 1 ) , another investi @:A.tor, is in 
accord with the above findings. 
It remained for Grea.ves ( .s 'I ) to demonstrate 
thRt bile is necessary for the absorption of Vitamin 
K by the rat, and that in animals subsisting on a diet 
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deficient in Vitamin K, bile has no effect on the 
hemorrhagic tendencies, whereas, Vitamin K and bile 
salts are effective immediately. 
These investigators, in their exneriments 
and demonstrAtions in the rAt, dog and in man, have 
shown fairly conclusively that bile acids act as 
carrying agents for the nassage of the fat soluable, 
Vitamin K, across the intestinal mucosae. 
The exact site of Absorption of Vitamin K 
through the intestine has not been definitely proven. 
However, work performed by Dixon and Clark of Mayo's 
( 2 5 ) indicates that the jejunum is the site where 
the absorption is at its maximum, while it does not 
seem to be absorbed by the stomach or colon. In sub-
stantiation of jejunum as the site of absorption, we 
might quote Snell's statement to the effect that in 
cases of Sprue and Hegional Ileitis, "deficiency of 
prothrombin because of an insufficient intestinal ab-
sorntion of Vitamin K, hAs been noted I!. ( (,7 ) 
The answer to the auestion of prothromhin 
~orrnRtion and the role played by Vitamin K in this 
process is being sought by a number or investigetors, 
rit nresent. "There is considerable evidence that the 
liver is the chief, if not the only site of formation 
of prothrombin, and that an a&:rna.te amount of normally 
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functioning liver tisfme is essential for the proper 
utilization of Vitamin K in this :orocess." ( .l 1 ) 
Warner ( 7 J. } offers support to the above 
statement with his ·work on albino rats. He found 
that "extirpation of a large portion of the liver in 
rats resulted in a marked decrease in the nlasma pro-
thrombin". The nlasma prothrombin 1 evel gradually 
returns to normal during the neriod required for 
restorAtion of the liver to its normal weight. 
Roderick ( {p/ ) renorted in 1929, thAt cattle 
that ~vere fed toxic sweet clover suffered from marked 
hynoprothrombinemia and hemorrhage. Autopsy revealed 
liver necrosis. 
Recently, Smith, Warner and Brinkhous { (p S' } 
renorted a bleeding tendency in dogs that were in-
flicted with chloroform intoxication. Plasma pro-
thrombin decreased in proportion to the liver injury. 
3ni th, Hoff.man ( G. r, ) and other investigators 
on this subject are agreed that the evidence compiled 
to date points strongly towards the liver as the site 
of formation of ~rothrombin. At present, little is 
known of the chemistry of prothrombin. Undoubtedly, 
rt=ipid strides in the investigBtion of nrothrombin and 
its source will take nlace, as soon as more is known 
of prothrombin ner-se. 
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Recent investigations of Greaves indicate that 
Vitamin K is not stored in apnreciable qurmti ties in 
the liver of rats. ( fo ) This necessitates the find-
ing of a possible endogenous source of Vitamin K, in 
order to explain how, in the absence of Vitamin K from 
the diet, experimental animals maintain prothrombin 
levels within normal limits for long periods of time. 
Greaves ( )'f ) investigated the nossible manu-
facture or synthesis of Vitamin Kin the intestinal 
tract. He found the anti-hemorrhagic factor in the 
dronnings of chicks, which he collected and extracted 
and gave to chicks suffering from low prothrombin 
levels and hemorrhagic tendencies. The extract of 
droppings was added to a diet of K avitaminosis. These 
findings annarently substantiated the assumption that 
Vitamin K was synthesized in the intestinal tract by 
bacterial action. 
Almquist and ~'tokstad ( 3 confirmed the a-
bove findings and concluded that the vitamin was evi-
dently synthesized by bacterial action, either after 
the droppings were voided, or within the lower portion 
of the digestive tract where absorption could not 
readily take place, or both. In order to ascertain 
where the synthesis took place, they performed the 
following experiment. 
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The modified basal diet of lilmquist ( .3 
w11.s given to chicks up until they were four weeks 
Of age. '11.h.e basnl diet is as follows: 
1. Ether extracted fish meal l?.5 
2. l:!.'ther extracted dried Br evver' s 
yeast ?.5 
3. NaCl plus small amounts of cupric 
and Ferrous Sulfate 1.0 
4. Cod Liver Oil 1.0 
5. Ground polished rice ?3.0 
This diet cont11.ins ingredients anproximately, 
as follows: 
Protein 








0 • 91/o 
The above diet, when suunlemented with the 
anti-hemorrhagic factor, allows chicks to maintain 
good health and normal growth. The diet not so sup-
plernented causes severe hemorrhages and eventual 
death. 
Droppings from these four week old chicks 
were collected after the feces had dropped into trays 
containing 1% Phenol in aqueous solution. The ration-
ale of the Phenol was to inhibit further bacterial 
action. '11.h.e droppings were collected At 24 hour inter-
vals. The droppings were then dried by severAl changes 
of ether. 
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The alcohol and ether extracts were mixed and 
diluted with a large amount of water. The ether solu-
tion was washed several times with sodium hydroxide 
solution and WAter. .As a source of anti-hemorrhagic 
vitamin, the ether solution was found to be adequate 
at an equivalent level of 870, marginRl at 470 and in-
adequate at 2)a. The notency of the solution was 
somewhat less than that of the extract obtained from 
droupings falling on the ground. 
Later, Almquist, et al, ( 9 showed that 
bacteria, in the following manner, are essential to 
the synthesis of Vitamin K: 
1. Fish meal sterilized gAve no nrotection 
to chicks; 
2. Ii:tsh meal, nlus bacteria, nrotected chicks 
against hemorrhage. 
Recent observations of Almquist, Pentler, and Meechi, 
( ? ) and Snell ( tJ,7 ) indicate th11t an anti-hemorr-
hagic factor possessing similar qualities as found in 
Vitamin K, is present in certain s~ecies of bacteria, 
namely, Escherichia coli, Staphylococcus aureaus, 
Bacillus subtilis and many microorganisms. 
Recently, .Ansbacher and Fernholz demonstrated 
the Vitamin K r-i.cti vi ty of phthiocol, which contAil'l~,'( 
the naphthoquinone nucleus. This nucleus is found in 
Vitamin Kl. and Vitamin K2 and the pigment of :Mycobac-
terium tuberculosis.( 13 ; 
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These observations indicate Vitamin K, or 
Vitamin K like substances, are nresent in certain 
species of bacteria and are the product of bacterial 
metabolism. 
While much has been accomplished, there still 
remains a considerable amount of investigation of the 
role played by bacteria in the nroduction of Vitamin 
K, or Vitamin K like substances, in the intestinal 
tract. Whether such a role will nrove important or 
not, remains to be disclosed in the future. 
- 24 -
CLINICAL ESTIM 1\TI ON 
The nresence of VitAmin K deficiency is de-
tected clinically by the demonstration of a decrease 
in plasma prothrombin. 
Howell ( tt ) used the clotting time of re-
calcified plasma as A meRsure of the prothrombin 
present. However, (luick ( .53 ) pointed out that in 
reality, the so-called ttHowell' s Prothrombin Timer' 
method does not aPPArently determine prothrombin time, 
as the thromboplastin from the Platlets is even more 
imnortant in influencing the clotting time than is 
nrothrombin. 
Warn er, et al, ("10 ) originated A met-. hod for 
the aur:i.nti tritive estim::ition of PlA.smn nrothromhin which, 
al though very exact and nrec ise, is regarded as too 
complex for routine use in the clinicAl laborr-itory. 
7'.1uir -::1ethod for the quanti tA.ti ve estimation of plasma 
prothrombin ( "lo differs from '{,uick' s method in the 
following mr-i.nner. ',J,uick, et al, use the total clotting 
time, which is made up of the prothrombin conversion 
time and the time required for the thrombin to react 
with the fibrinogen. Warner, et al, separated the two 
phases by converting the prothrombin to thrombin, then, 
by merins of a serial dilution technique, the thrombin 
that is formed may be titrnted. 
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:!:Jr eviously, the prothrombin wrrn 1:) arti rilly 
altered in nreliminary nurificRtion, or wns converted 
incomnletely into thrombin. Often the thrombin form-
ed wns Allowed to disintegr11te nartially before 
ti trntion, with resul trmt wer-ik thromhin solutions 
which renresented a small and vnrinble fraction of 
the total plasma prothrombin. 
In Warner's method, care hr-is been taken to 
effect complete rind rBnid conversion of prothrombin 
to thrombin. .Also, by making the serial dilutions 
before activating the prothrombin instead of after the 
thrombin has been formed, the possibility of thrombin 
disintegration has been mitigated. This so dilutes the 
tmti-thrombin thnt it does not interfere ,Ni th the 
ti trnti on. "The nroblem of fixed stt?TidArds has been 
solved by using a standard clotting interval as a 
fixed noint. The degree to which the unknO\m solution 
is diluted in reaching this point, gives a measure of 
the amount of thrombin present. We are then able to 
exnress this amount in uni ts of dilution." ( ?o ) 
"The nrothrombin of pla.smn can be converted comnletely 
into thrombin by adding an optim11l amount of calcium 
and an excess of thrombonlastin. For convenience in 
this work, we hnve defined thrombin of unitary concen-
tration as being of just sufficient strength so that in 
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the presence of fibrinogen (0.08 - 0.10 nercent), it 
will form a clot in fifteen seconds. rlhe pH of the 
reagents is adjusted to 7.4 and the titration is 
carried out at a room temnerature of 28 degrees c. 
Prothrombin of unitary concentration is defined as 
being of sufficient strength, so th!:!t when completely 
converted, it will fom. an equal volume of uni tAry 
thrombin." '70 ) 
The reagents used, are as follows: 
1. Oxalated saline; 
2. 1~ssue extract (thrombonlastin); 




For the prenarntion of the above mentioned re-
agents, the reader is referred to the original article 
of Warner ( 7o ) • 
The nlasma is defibrinated before titration is 
carried out. This is accomnolished by using thrombin 
for the defihrination. The thrombin is prepared by 
mixing three drons of tissue extrAct, cnlcium .'3nd nlAsma, 
with six drons of sr-iline. The thrombin is expressed 
from this mixture and used At once. "Thirty drops of 
the plasma were now defibrinAted by adding three drops 
of thrombin. A clot is formed in eighteen seconds. 
After allowing fifteen minutes to insure complete clot-
ting and destruction of excess thrombin, the fibrin w11s 
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rolled out. The exnressed fluid, containing the nro-
thrombin Vias diluted 1-20, 1-30, and 1-40, with 
oxalnted sriline. ',~hen tested for thrombin, these 
solutions did not clot fibrinogen. To test them for 
prothrombin, we mixed three T)arts of eCTch with three 
of saline, three of calcium nnd three of tissue ex-
tract. After sui t.qble Deriods of incubation, we 
Added three drons of fibrinogen to twelve drops of 
eRch incubated mixture. The clotting WtlS then meas-
ured with a ston watch. From data already given, 
the total pl11sma dilution can be calculated. 11 ( ?o 
"The thrombin concentration tynically rises to a 
plateau, which is maintained for a safe interval of 
time. " ( ?() 
In their example, the nlateau of thrombin 
showed a fifteen second clotting time w1 th the plasma 
diluted 1-223. Therefore, the nrothrombin unit concen-
tration v1ould be 223, since one unit of thrombin, 
according to Warner's definition, is eou11l to one 
unit of nrothrombin. 
The Above findings were of dogs. In estimating 
the nrothrombin content of human nlasma, lower concen-
trations will be f'ound. Two modif'ications were made, 
later. The PlAsma is defibrinated by their thrombin 
preparation, which is added to the plasma. The thrombin 
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is so diluted th,,t a clot forms in 15-18 seconds. rI'he 
second change is the usAge of acacia. The result is thnt 
higher 'brothrombin uni tage" is possible. ( 1 / } 
(:~).lick, et ril, ( !13 } by I'WA.ns i)f a new test, 
vrnre able to determine prothrombin levels in the plasma. 
A complete account of the procedure can be found in the 
original article ( 53 } • 9 c. c. of blood were withdrawn 
rapidly and mixed with 1 c.c. of M/10 sodium oxalate, and 
then cintrifuged at low speeds for 5 minutes. bmall 
amounts of the plasma, 0.1 c.c., were transferred to a 
dry clean test tube, 13xl00 m.m., and mixed with equal 
amounts, 0.1 c.c., of thromboplastin solution. Next, 
O.l c.c. of M/40 calcium chloride was added and the mix-
ture quickly shaken 1'!nd nlaced in w11.ter, both at 37 
degrees c. "The exA.ct time required for the formation 
of a solid clot is recorded. n ( .s 3 ) 
If active thromboplastin is used, normal human 
plasma should clot in 22 to 25 seconds. Assuming that 
the clotting time is dependant on the prothrombin con-
centration, any dilution of nlasma should produce a 
delay in the coagulation. 'I'his actually occurs, as 
~.:,uick has proven. 
Increased amounts of thromboplastin are added 
to the plasma, which has been diluted so that the 
prothrombin has been reduced to 1/5 of normal. The 
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clotting time is increased to 65 seconds. In order 
to mitigate the possibility that the prolonged clot-
ting time is due to dilution of some other consti tu-
ent in the ulasma, dilutions were made with normal 
saline and plasma thAt had been tre~ted with aluminum 
hydroxide. The aluminum hydroxide removes or inacti-
vates prothrombin with no apnarent change resulting 
to the other constituents of the plasma. The results 
were the same, indicating that the decrease in plasma 
prothrombin is responsible for the plasma clotting 
time. In order to have standard results and carry out 
the prothrombin test successf'ully, it is necessary to 
have an active and stable thromboplastin. 
Rabbit's brain proved most efficacious as the 
source, since it is both active and stable. The pre-
paration is as follows: Remove superficial blood 
vessles from the brain of rabbit, \'lash and grind to a 
paste and spread on a glass in thin layers; dry at 37 
degrees c.; remove material and place in stoppered cai-
tainer; then add 0.2 gm. of this material to 0.3 c.c. 
of 0.85% sodium chloride and mix, then incubate for 
15 minutes. This emulsion, when added to plasm.a 
(human), causes clotting in 22 to 25 seconds. This 
emulsion is stable. 
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~uick brings out the fact that F:tbrinogen, 
which is in the plasma normally at concentrations of 
0.3 to o.?5~, plays a passive pArt in the role of 
clotting. (SJ) However, total absence of Fibrino-
gen has been renorted by Rabe and Saloman ( 58' ) , and 
Opitz and Frei (So ), with ensuing fatal hemorrhage. 
Regarding calcium, Quick says that, contrary 
to common belief, it seem.s more likely that only 
organically combined calcium is directly essential 
for the form.Ation of thrombin, and not the ionized 
calcium of the blood. 1>,uick uses Scott's and Cham-
berlain 's ( h?i> findings in this article. They demon-
strated that the quantitative removal of ionized cal-
cium from the blood with oxalate, will not prevent 
clotting. 
~uick ( s+ ) later revised the quantitative 
determination of prothrombin, as follows: 
1, 4.5 c.c. Blood plus 0.5 c.c. Sodium 
Oxalate solution, centrifuged; 
2. 0.1 c.c. plasma nlus O.l c.c. thrombo-
plastin• 
3. O.l c.c. Calcium Chloride then added 
quickly, after which, observe the length 
of time it takes to clot. 
Normally, this will be 12 to 13 seconds. With a de-
crease in prothrombin, the clotting time is delayed. 
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By means of the following chart, the nrothrom-
bin content can be determined: 
10 
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A simple bed side test for the clotting time 
has been perfected by Ziffren, Owen, Hoffman and 
3nith ( 75 ) • It is a simnlification of 'filick''s test, 
and like his so-called "prothrombin test", measures 
not only prothrombin, but the slllllID.ation of several 
variables, thus giving a practical test for the ten-
dency to bleed. 
The test is run as follows: 
1. O.l c.c. of thrombonlastin is nlaced in 
a 3 c.c. tube; 
2. 1.0 c.c. of freshly drawn blood is run 
into the tube; 
3. 'J1he tube is inverted once, and then gent-
ly tilted every few seconds; 
4. The clotting time is observed; 
5. Repeat test on a normal individual, then 
the unlmown is exnressed in percentage 
of the normal, as expressed by the fol-
lm•.ring formula: 
Clotting Ac ti vi ty _ Clotting time of normal 
(In ~o of Normal) - Clott:'_nr~ time of unknoV'rn x l0n 
The thrombonlastin is prepared as follows: 
"Ex:tract 10 gm. gound brain or lung (ox or rabbit\ 2 
hours with 10 c.c. saline; strain and preserve in re-
frigerator." "Variable potency does not affect the 
clotting time ratio of unlmown to control. If normal 
values exceed 60 seconds, the thromboplastin is rejected; 
if less than 25 seconds, one should dilute the thrombo-
plastin with saline." ( 75 
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The originators of this new test comnared this 
test with the quantitative nrothrombin test of Warner. 










1"Toxic Hepoti tis" 
Obstr. Jaundice 
Sex New Test Quant. Prothrom-
(% of Normal) bin Test {% of 
Normal) 
F 100 98 
M 93 83 
F 90 92 
M 76 80 
M 62 73 
M 60 60 
F 50 49 
M 41 46 
M 31 23 
M 22 13 
For all intents and nurposes, the above test 
or Quick's test, prove satisfactory for the clinical 
use. Many clinicians and techniciA.ns modify the Quick 
test by using less blood. The r3tio of the remaining 
constituents is not changed. 
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BILIARY FISTULA AND 
OBS'-~RucrrIVE JAUNDICE. 
"The earliest renorted case of fatal bleeding 
in a patient having jaundice was made by Wedelius, in 
1683." ( 7 r' ) ( ,_5 ) Since the advent of aseptic 
surgery, the tendency to bleed in natients hnving 
jaundice has been helplessly noted. This condition 
has caused grave concern to surgeons, innumerable 
times. The syndrome, jaundice, then bleeding, and 
then death, occurred so often it became almost an.edict 
of surgical hierarchy, that to onerate on such cases 
meant death for the patient. 
lt"'rom the time Wedelius first renorted the 
syndrome in the literature, up until c:,uick made his 
observations, little effective treatment was forth-
coming to the afflicted. This was not because effort 
h.qd not been ex11ended, but quite the contrary, for in-
vestigators have literally turned the gall bladder 
inside out, seeking the answer. 
Greaves and Schmidt ( 9t ) , in 1933, demonstra-
ted that little or no irradiated ergosteriol is absorbed 
from the bile fistula rat ( - ) • However, when desoxy-
cholic acid was administered by mouth, it served as a 
carrier of irradiated ergosterol across the intestinal 
wall of the bile fistula rat. This work proved that 
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bile salts are needed for the absorption of fat solu-
able vitAmins, such AS VitAmin D. 
Their work WAS the outgrowth of }Javlov, Looser, 
V/isner, Whipule, Seidal ·And other early investigators, 
who pointed out the fact that exclusion of bile from 
man snd certain other animals leads to Osteonorosis. 
Seifert ( (,'I ) suggested that in the absence of bile, 
Vitamin D is not absorbed, which consequently leads to 
a negative calcium and phos:ohorous balance. 
1I1his work played an important part in discover-
ing the mechanism of Vitamin A and Vitamin D. Years 
la.ter, it again was to be used in expl11.ining the mechan-
ism of Another vitamin. This Vitamin is K. 
Dam and his associ0tes, while worldng on experi-
ments with chicks, :found thr-it if certain factors are 
missing from the diet, a hemorrhagic condition ensues. 
They lAter found certain foods would alleviate this 
condition. 1bus, Vitamin K was born into the world, and 
from that time on, has been subjected· to the scientific 
scrutiny of investigators anxious to clear up the enigma 
of hemorrhage in jaundiced patients. 
Vitamin K was found in alfalfa and other leafy 
substances, the photosynthetic nortion of plants. Next, 
it wris found in putrified fish, in eggs, in hog liver 
oil, in hemp seed and many other sources. 
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studying these factors. They, therefore, developed 
a method for nrothrombin detection and for the pre-
naration of a stAble and active thrombonlastin. "In 
studying the nl!'.l.smn from various types of ,inundiced 
natients by this new method for determining prothrom-
bin, it WAS found that this component was greatly 
diminished. Instead of obtaining a normal clotting 
time of 22 to 25 seconds, a delay, which in one case 
was as long as 90 seconds, was obtained." ( S3 ) 
"'These findings, therefore, suggest that the hemorr-
hagic tendency in Jaundice is brought by a diminuation 
of prothrombin." ( 53 ) 
This suggestion by Q:uick nroved to be a tre-
mendous boost for the search of the cause of hemorr-
hage in Ji:wndice. 
The first direct evidence reported in support 
of the new theory was supplied by Greaves and Schmidt 
( 't-.:L ) • They showed that when rats w:i.th biliary fistu-
las were maintained on a low fat diet for periods of 
30 to 50 days, a small scratch would result in prolonged 
bleeding, v.rhich in some cases led to the death of the 
animal. 
Quick' s method for deterrninj_ng the prothrombin 
found that the loss of nrothrombin closely narall eled 
the hemorrhagic tendency. It was fUrther noted that the 
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prothrombin content of these animals would have to be 
reduced to 20'/o to 30'/o of normal, before the coagula-
tion time of the blood was markedly reduced. A marked 
rise in the prothrombin content of the blood was noted 
to take nlace within 2 to 4 days after the administra-
tion of 2 to 3 c. c. of beef bile. Vii th the increAse in 
prothrombin content, a decrease in clotting time was 
noted. 
Vita.min K extracts, when fed to the bile fistula 
rats, were effective in decreasing the clotting time 
and increasing the prothrombin content. 
Next, the rats were made icteric by ligation of 
the bile duct, and fed a stock diet. The stock diet 
contained Vitamin K. A decrease in prothrombin content 
was noted, and soon, the re-establishment of the flow 
of bile into the intestinal tract and an increase of 
prothrombin was noted in the plasma. Only when massive 
doses of VitAmin K, without the bile salts or bile 
itself, were fed, did the ~rothrombin rise to normal 
levels. They concluded, therefore, "that ( l} bile 
fistula rats show loss in blood coagulability and a de-
crease in the prothrombin level; (2} this condition can 
be relieved by administration of Vitamin K concentrate". 
( f Z. ) 
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Two months later, Warner and associA.tes ( '?~ ) 
renorted the first successful treatment of human 
patients. They say in their article, "We have followed 
the prothrombin level in human cases, in which bile 
feeding was supplemented with a fat soluable extract of 
alfalfa meal. The residue of a petroleum ether extract 
of 200 to 400 gm. alfalfa meal was emulsified in human 
bile, or, in some cases, in 27b sodium taurocholate 
solution, and fed daily. In a number of patients given 
this alfalfa-bile mixture, even with persistance of 
Jaundice, the rise in nrothrombin was very rapid. If 
bleeding existed, it soon ceased. In three cases of 
Obstructive Jaundice, the prothrombin level before 
therany was 43, 20, and 37%. .Alfalfa with bile or bile 
salts was given for 6, s, and 6 days, resnectively. 
At the end of the period, the prothrombin values had 
risen to 86, 107, and 102%. The rise in these cases 
is considerably faster than with simple bile feeding." 
( 7.3 ) 
Shortly after Warner and associates published 
their article, Butt, Snell and Osterberg of the Mayo 
Clinic, renorted their findings regarding the usage of 
Vitamin Kand bile salts in the treatment of low nro-
thrombin content of patients suffering from Obstructive 
Jaundice. (?J Their renort confirmed the findings 
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of WA.rner, et al. Eighteen pA.tients with Obstructive 
Jaundice were used in their clinical trial of Vitamin 
K. They found that Vitamin K is not effective unless 
given with bile salts. Bile given 11lone, will effect 
a decrease in the clotting time, but it is a Rrndunl 
and relatively ;:;low decline, whereas, bile sA.l ts plus 
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The clinical findings and observations of 
Stev.rart ( ~ f ) , 01 son ( 9f ) , Rhoades ( 5 9 ) , Johnston 
( "/{, ) , Sceil-on, et al, ( "~ ) , Dam and GlQvind (3 Y ) , 
and others, hnve confirmed the reports of Warner, et al, 
and Butt, et al, which showed thf.lt the bleeding tendency 
in biliary fistula rmd obstructive jaundice was due to 
a lack of Vitamin K absorption in the absence of bile 
from the intestinal tract. This led to a low prothrom-
b in content and R subsequent increase in the clotting 
time of the blood. 
Greaves ( 3 'I ) added conclusive proof to these 
clinical findings with his experimental findings unon 
rats. He showed that in the rats, Vitamin K is carried 
ncross the intestinal trAct by means of bile salts. In 
the absence of Vitamin Kor bile salts in the rat, a 
lowered prothrombin time occurs, with an increase in the 
clotting time. Hugh R. Butt, et al, ( .25 ) state the 
following: "Even current figures indicate that cholemic 
bleeding has accounted for about fifty percent of the 
mortality accompanying surgical intervention on patients 
having jaundice, and that cholemic bleeding, of itself, 
imposes a surgical risk of annroximately five percent.n 
The understanding of cholemic bleeding that 
these investigators and others have given the medical 
profession should prove to be "a big stick" in striking 
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down the mortality and surgical risk on patients so 
afflicted. In disclosing the causitive factor, they 
disclose the treatment, for from their work, we see 
that the cause is mainly due to a deficiency of 
Vitamin K, a deficiency caused by lack of absorption 
through the intestinal tract in the absence of bile 
salts. Thus, a viscious cycle can be broken by addi-
tion of bile and an adequate amount of Vitamin K. 
The writer, in this paper, has endeavored to 
set out in chronological order, the research and 
discoveries that have lead to the present Jmowledge 
of Vitamin K's role in jaundice, due to biliary 






In summarizing, we find the following facts: 
Cholemic bleeding has been known for centuries. 
In obstructive jalllldice and biliary fistula1 there is an absence of bile from the intestlnal 
trA.ct. 
Bile salts are necessary for the absorption of 
Vitamin K across the intestinal tract. 
Vitamin K in large dosages will restore the 
prothrombin content to within normal levels. 
Bile salts taken with Vitli'.llin K prove to be more 
efficacious as a method for restoring the pro-
thrombin content to normal. 
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THERAPY: BILI.ARY FISTULA 
.A.ND OBSTHUCTIVE JAUNDICE. 
Cantarow has covered the treatment of biliAry 
fistula and obstructive jaundice more thoroughly than 
other investigators, and we quote from him: 
"Vi tr-imin K therapy at the moment is in a tran-
sition stage, owing to the recent demonstration of the 
chemical nature of the vitamin and the availability of 
synthetic preparations which vdll undoubtedly replace 
extracts which have been employed heretofore. Prepara-
tions made from alfalfa and other grains (wheat and oats} 
and fish meal have provided the most potent sources until 
recently. 'Ihe commercial preparations in most common use 
are IG.otogen (.Abbott} and Cerophyl (Cerophyl Laboratories). 
The latter is available in tablet and powder form and the 
former in soft gelatin capsules (1000 Almquist and Stok-
stad units; 37,500 Dam units} and in 50 cc. vials, each 
cubic centimeter of which contains 1250 Almquist and 
Stokstad units. The Dam unit is defined as the amount 
of antihemorrhagic material contained in 2 mg. of dried 
spinach. These meAsures of unit value are obviously of 
limited usefulness and will undoubtedly be discarded now 
that pure nrenarations of the vitamin are available. 
It has been suggested recently that a unit of Vitamin K 
activity should be regarded as equivalent to the 
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antihemorrhagic effect oI' 1 microgram of nure 2 methyl 
-1, 4-naphthoquinone. 
"In the treatment and prevention of the hemorr-
hagic tendency of patients with obstructive jaundice 
and bile fistula, before and after operation, Cerophyl 
has been given effectively in doses of 5-25 Gm. daily. 
Klotogen is usually given in the dosage of one capsule 
three times daily or, in severe cases, 8 cc. of the 
solution in oil may be administered daily by duodenal 
tube. In such cases bile salts should be administered 
in conjunction with the vitamin. 'v\fuole bile or bile 
concentrates may be given. Bile salts are perhaps to 
be preferred, in doses of 1-2 Gm. of sodium taurocho-
late and glycocholate or, preferably, deoxycholic acid, 
in the dosage of 3 grains {0.2 Gm.) three times daily. 
Synthetic, crystalline Vitamin Kor one of the several 
similar naphthoquinones which have been shO"wn. to nossess 
Vitamin K activity are now being used. These prepara-
tions seem to be effective in doses of 1-2 mg. daily, 
by mouth. Bile salts should be given simul ttmeously, 
as stated above. They have also been found to be effect-
ive when given parenterally. 
"In the great majority of cases of obstructive 
jaundice and bile fistula, the plasma prothrombin in-
creRses nromptly after the institution of this form of 
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therapy and usually returns to normal in a few daYs. 
A similar effect may frequently be produced by the 
oral administration of whole bile, bile concentrates 
or bile salts, without Vitamin K, the latter being 
present in the food and in the intestine but inade-
quately absorbed because of the absence of bile 
S.9.1 ts. HoV1rever, the increase in -prothrombin under 
such circumstances is usually much more gradual than 
if Vitamin K is given in excess simultaneously. As 
stated nreviously, occasional failure of Vitamin K 
therany may be due to the presence of extensive 
hepatocellular damage. 
11 According to l<,uick, if the prothrombin con-
tent of the blood is below 15 per cent of normal, 
transfusion should be resorted to. The effects are 
transitory and this procedure should be used only as 
an emergency measure to supplement Vitamin K and bile-
salt therauy. The observations of Lord, .Andrus and 
Moore indicate th3t the changes in plasma prothrombin 
of the recipient of a transfusion are dependent on the 
prothrombin content of the blood of the donor, and may 
be calculated on the basis of addition. Stewart found 
an increase of only 6 per cent in one case after trans-
fusion of 600 cc. of blood. Blood from "blood banks" 
should not be used b~cause its prothrombin content is 
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apt to be low. According to Rhoads and Panzer, 
blood that has been ureserved for a. week: or more is 
Dractically useless for this nurpose and thA.t kept 
for 3 days is of only slight value. 
"Since the nlasma prothrombin may fall quickly, 
esuecially after operation, determinations of this 
factor must be made frequently during the pre- and post-
operative neriods, even though no deficiency is found, 
and adequate Vitamin Kand bile-salt therany rm.ist be 
provided before and after ODerA.tion unon :OA.tients with 
obstructive jaundice and bile fistula." (a.1) 
The above finding agrees with the majority of 
investigritors in this field. ( .n, .:i ~ ;i.s, ~ '· .1 t; 1.,1s, "? ) 
'I"· .s; ¥, s '· (,. o. ":i. 't. t-, ~,, 7J, 7.5", 
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SUMMARY 
1. A new vitamin has been discovered and 
named nvi tamin K0 by Hendrik Dam. 
2. Recently, another form of the vitamin 
has been isolated, nRmely, Vitamin K2. The struc-
tural and dmperical formula has been found for 
Vitamin Kl and Vitamin K2. The synthesis of Vi ta-
min K like substances has been performed in the 
laboratory. 
3. The vitamin is found in varying amounts 
in plants, fish and bacteria. 
4. The vitarain contributes to the formation 
of prothrombin in the body, without which aid, the 
tendency to hemorrhage appears. 
5. 'l'he method for estimAting the Vitamin K 
utilization in the body is based upon the prothrom-
bin content of the plasma. A l°'v prothrombin content 
signifies a low intake of Vitamin K, or poor utiliza-
tion by the body. 
6. Bile salts convey the vitamin across the 
intestinal tract. A deficiency of bile salts results 
in decreased absorption of Vitamin K by the intest-
inal mucosa and a subsequent increase in the clotting 
time. In obstructive jaundice and biliary fistula, 
bleeding mal{es operating a poor risk. 
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7. 'lherapy is designed to raise the pro-
thrombin time and decrease the clotting time. Bile 
salts with Vitamin Kare given preoperatively and 
postoperatively. 'lhe result of therany is gauged 
by prothrombin estimation. 
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